Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques
Looking for Biomarkers in Human Joint Fluid Using Metabonomic, Microbiomic and Tribological Analysis
1 other identifier
observational
150
1 country
1
Brief Summary
Making the diagnosis underlying a painful, swollen joint currently involves aspiration followed by numerous microbiological and biochemical laboratory tests. This can be costly, time consuming and in the case of an acutely swollen joint, lead to a lengthy inpatient admission. There is an unmet need to provide a quick, easy, reliable dipstick like test to analyse joint fluid in the community, clinic, or emergency department setting. The investigators aim to use well established metabonomic techniques to:
- 1.Analyse fluid from patients with swollen joints
- 2.Identify potential biomarkers of inflammatory, infective and osteoarthritic causes of joint swelling
- 3.Correlate this with lubrication and wear properties of the fluid The long term goal is to develop time saving, cost effective, non-invasive diagnostic tests to improve management of a swollen joint. The biomedical research centre at Imperial provides a unique and unparalleled clinical and scientific environment to conduct this research. The Imperial College division of Computational and Systems Medicine has an international reputation in metabonomics and this, together with the high volume of patients with swollen joints treated at Imperial National Health Service Trust (c1000/yr) ensures that the study can take place in an environment conductive to success.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2015
CompletedFirst Posted
Study publicly available on registry
October 1, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedAugust 20, 2019
August 1, 2019
6 years
May 28, 2015
August 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic profiling of all three body fluids in 100 + patients
14 months
Secondary Outcomes (1)
DNA Profiling of 100 Joint fluid samples for the assay of the microbiome
14 months
Study Arms (3)
Septic Arthritis
Patients suspected of having septic arthritis
Osteoarthritis
Patients suffering with osteoarthritis undergoing an intervention
Joint Revision
Patients who has a prosthetic joint in situ
Interventions
Procedural sampling of the joint for diagnostic purposes
Procedural washout for treatment purposes
Eligibility Criteria
In summary we expect to recruit 150 subjects and sample three body fluid types. In some cases control and multiple time points will be collected.
You may qualify if:
- The patients will be recruited in several scenarios.
- Anyone receiving a diagnostic aspirate of joint.
- Patients undergoing joint arthroscopy
- Patients undergoing joint replacement
- Patients undergoing prosthetic joint revision surgery
You may not qualify if:
- No patient under 16 years or age or older than 80 years will be entered for the study.
- Any female patient who is pregnant will be excluded.
- Any patient medicated with anti-coagulants will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College NHS Trust
London, W2 1NY, United Kingdom
Biospecimen
Blood, Urine and Joint Fluid
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chinmay Gupte, MBBChir
Imperial College London
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2015
First Posted
October 1, 2015
Study Start
October 1, 2015
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
August 20, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share